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The purpose of this study is to demonstrate the benefits of 
enhancing adsorptions with PEG. Allogeneic adsorptions were 
performed on 20 patient samples containing warm reactive 
autoantibodies with two volumes of adsorbing RBCs; results 
using unenhanced adsorptions were compared with those using 
PEG-enhanced adsorptions and with using untreated adsorbing 
RBCs and ficin-treated adsorbing RBCs. Two volumes of adsorb-
ing RBCs, one volume of serum, and one volume of PEG were 
used. The number of adsorptions, average time saved, and pres-
ence or absence of underlying alloantibodies were compared for 
the two methods and types of adsorbing RBCs. Modified PEG-
enhanced adsorptions resulted in a 69 percent decrease in ad-
sorbing time. PEG adsorptions removed all autoantibodies and 
detected 18 of 19 underlying alloantibodies. The unenhanced 
method did not remove autoantibodies in two samples and 
identified only 15 of 19 underlying alloantibodies. As expected, 
reductions in the number of adsorptions and adsorbing time 
were observed. The modified-PEG adsorption is an improved 
method that may replace the current unenhanced method. 
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Patients with warm-reacting autoantibodies who dem-onstrate immune hemolysis are generally symptom-atic with critically low hemoglobin levels, requiring 
urgent transfusion to treat their clinical symptoms. The 
evaluation of these patients’ samples requires adsorption 
procedures, which are labor-intensive and time-consuming. 
PEG is added to the adsorption mixture to decrease the 
number of adsorptions performed, shorten the length of the 
adsorbing procedure, and facilitate complete removal of the 
autoantibody.1 PEG is a water-soluble polymer that enhanc-
es antibody interaction by excluding water molecules dur-
ing antigen and antibody interactions, allowing for a closer 
proximity of antibodies to antigens.2 PEG can be an irritant 
in routine testing because it enhances reactivity of auto- 
antibodies. However, in the adsorption procedure, it is help-
ful by because it enhances the adsorption of autoantibody 
onto the adsorbing RBCs.3 The purpose of this study is to 
investigate whether double-volume allogeneic adsorptions 
performed with either untreated or enzyme-treated (ficin) 
allogeneic adsorbing RBCs using PEG as an enhancement 
are more efficient and more effective in removing autoan-
tibody, while leaving alloantibody in the absorbed serum, 
than adsorptions performed without PEG.
Previous PEG adsorption studies used a testing ratio of 
one volume of serum, one volume of adsorbing RBCs, and 
one volume of PEG. The 1:1:1 (serum to RBCs to PEG) ratio 
has led to questionable underlying alloantibody recovery 
and the inability to completely remove the autoantibody in 
some cases. Although the PEG adsorption method requires 
less time than the established reference method, time saved 
must be optimized while maintaining the integrity of the 
test and the ability to identify clinically significant alloanti- 
bodies.
 Prior studies performed using untreated, ZZAP, or 
ficin-treated adsorbing RBCs with PEG enhancement show 
promising results. Leger and Garratty4 studied 39 samples 
in which all alloantibodies after PEG adsorption exhibited 
reactivity greater than or equal to that observed in the ZZAP 
method. The alloantibodies recovered in their study includ-
ed antibodies from all of the major blood groups. Barron 
and Brown3 had mixed results with respect to alloantibody 
recovery. In their study, three alloantibodies were identi-
fied in the enzyme methods that were not identified in the 
PEG method; however, one antibody was found in the PEG 
method that was not found in the enzyme method. The au-
thors also found that five of the antibodies reacted more 
strongly after PEG adsorptions, although it seems very 
weak alloantibodies may have been lost with the PEG meth-
od. Judd and Dake5 found 7 of 12 samples had decreased 
alloantibody reactivity, notably attributed to immunoglob-
ulin precipitation observed when using PEG. The authors 
of both of these studies commented that their observations 
were inconsistent with other studies.
 Alloantibody recovery can only be measured if the au-
toantibody is completely removed. Liew and Duncan1 re-
ported complete autoantibody removal in all six samples 
tested. In their study of 16 samples, Cheng et al.6 reported 
3 samples in which the adsorptions did not remove all au-
toantibody with the unenhanced method, whereas all auto-
antibodies were removed with the PEG-enhanced method. 
Both methods in the Cheng study used untreated adsorbing 
RBCs.6 Judd and Dake5 reported four samples with the PEG 
method and five with the ZZAP method in which the auto-
antibody was not completely removed. The present study 
has been designed considering the success and failures of 
other studies.
 One advantage of the PEG-enhanced adsorption is the 
time saved in performing the enhanced adsorption 
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procedure compared with the unenhanced adsorption proce-
dure. Patients exhibiting autoimmune hemolytic anemia can have 
severely low hematocrits and exhibit life-threatening symptoms 
as a result of anemia. Decreasing the time required to per-
form the adsorption procedure will expedite the treatment 
of these patients. Leger and Garratty4 saved 16.75 hours in 
their study of 39 patients. Barron and Brown3 found that 
the PEG method averaged 30 minutes to perform, whereas 
the unenhanced method averaged 161.5 minutes. Cheng et 
al.6 reported a 40 percent decrease in the number of ad-
sorptions performed and an 85 percent decrease in the time 
needed to perform the adsorptions in a study of 16 samples 
using untreated adsorbing RBCs with PEG enhancement. 
Using double-volume adsorptions may save even more 
time.
Materials and Methods
 Twenty patient serum or plasma samples containing 
warm-reactive autoantibodies were provided by a local 
reference laboratory. With each patient, the same type of 
sample (serum or plasma) was consistent for all work on 
each given patient. Henceforth, these samples are all re-
ferred to as serum samples. Patient samples were preferen-
tially selected for the study to include as many underlying 
alloantibody specificities as possible. Eight samples with no 
underlying alloantibodies were included in the study as the 
negative control group. Because some patients have PEG-
dependent autoantibodies, a LISS detection method was 
initially used in an effort to identify and exclude the patients 
with PEG-dependent autoantibodies from the study. If the 
patient had a current or past RBC phenotype determined, 
a report accompanied the sample to aid only in the selec-
tion of the adsorbing RBCs and alloantibody identification. 
All identifying information was removed from the samples 
except for the patient’s historic phenotype.
 The strength of the autoantibody reactivity was deter-
mined by performing an antibody detection test with LISS 
(NHANCE, Immucor, Norcross, GA) enhancement.7 Reac-
tivity strength (as with all testing performed) was graded 
using the 0 to 4+ scale, as described in the current edition 
of the AABB Technical Manual.7
 The PEG, ficin, and Glycine soja reagents were 
prepared using standard methods by the participating Im-
munohematology Reference Laboratory (Blood Systems 
Laboratories, Tempe, AZ). PEG (Sigma, St. Louis, MO) 
and ficin (Sigma, St. Louis, MO) were prepared from pow-
der, and G. soja (Fearn, Mequon, WI) was prepared from 
soja seeds. Adsorbing RBCs were prepared as untreated 
(washed) and ficin-treated.7
Unenhanced Adsorption
 Two volumes of adsorbing RBCs (untreated or ficin-
treated) combined with one volume of patient serum were 
incubated for 30 minutes at 37°C (inverted to mix 2–3 times 
throughout the incubation). At the end of 30 minutes, each 
adsorption tube was centrifuged for 10 minutes at 3500 
rpm, and the serum was harvested. After the adsorption 
procedures, the absorbed sera were tested using LISS anti-
globulin technique against phenotypically similar RBCs or 
the adsorbing RBCs to determine when autoantibody was 
completely removed, after which alloantibody detection 
and identification were performed.
Modified PEG-Enhanced Adsorption
 Two volumes of adsorbing RBCs (untreated or ficin-
treated) combined with one volume of patient serum and 
one volume of PEG were incubated for 10 minutes at 37°C 
(inverted once during the incubation to mix the contents 
of the tube). The adsorption tube was then centrifuged for 
10 minutes at 3500 rpm, and the serum-PEG mixture was 
harvested. Four drops of the harvested serum-PEG mixture 
were then tested with one drop of phenotypically similar 
RBCs or with the adsorbing RBC, incubated at 37°C for 10 
minutes, washed four times with saline, and then analyzed 
with anti-IgG reagent. Negative reactions were verified with 
IgG-coated RBCs. Four drops of the serum-PEG mixture 
were used to account for the dilution caused by adding PEG 
to the adsorption mixture.
 Following the reference laboratory protocol, a maxi-
mum of four double-volume adsorptions were allowed to 
completely remove the autoantibody. If the autoantibody 
was not completely removed with four double-volume ad-
sorptions, then alloantibody identification was not per-
formed. When more than four double-volume adsorptions 
are performed, a dilutional effect may result (residual 
saline in the adsorbing RBCs that cannot be completely 
removed, which increases with each subsequent adsorp-
tion), and antibody detection results could be invalid.7 The 
serum-PEG mixtures were analyzed the day of preparation 
because of immunoglobulin precipitation that has been ob-
served on storage.8 Interpretation of allogeneic adsorptions 
are limited as the procedure will remove antibodies to high- 
frequency antigens present on the adsorbing RBCs.
 Time saved by performing fewer and shorter adsorp-
tions was averaged for all samples tested with each method. 
Time required for each adsorption was determined by add-
ing the adsorption time (30 minutes no enhancement and 
10 minutes modified PEG-enhanced) to the time required 
to harvest the adsorbed serum (10 minutes).
Results
 All of the modified PEG-enhanced adsorptions completely 
removed the autoantibodies, allowing for alloantibody de-
tection and identification. In comparison, autoantibody 
was not completely removed after four double-volume, 
unenhanced adsorptions in two samples. One untreated, 
unenhanced adsorption did not completely remove the 
autoantibody, whereas the ficin-treated cells without en-
hancement did completely remove the autoantibody in this 
sample.
Polyethylene glycol adsorptions
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 A total of 19 alloantibodies were identified after adsorp-
tion (Table 1). Fifteen alloantibodies (79%) were detected in 
the unenhanced method, and 18 alloantibodies (95%) were 
detected with the modified PEG-enhanced method. Three 
of the alloantibodies demonstrated stronger reactivity after 
modified PEG-enhanced adsorptions. The antibodies iden-
tified with the modified PEG-enhanced adsorptions and not 
with the unenhanced adsorptions all belong to the Rh blood 
group system (two each of anti-C and anti-E; Table 2). The 
antibody identified by unenhanced adsorption but not with 
the modified PEG-enhanced method was anti-e. An anti-C 
was identified with modified PEG-enhanced adsorptions, 
with ficin-treated adsorbing RBCs only. Not all samples in-
cluded in the study contained alloantibodies to differentiate 
true alloantibody activity from method-sensitive autoanti-
body activity that can confuse the final interpretation.
 Using PEG as an enhancement medium conserved time 
in the adsorption procedure. Unenhanced adsorptions re-
quire 40 minutes, whereas modified PEG-enhanced adsorp-
tions require only 20 minutes. Unenhanced adsorptions 
averaged 85 minutes, whereas modified PEG-enhanced 
adsorptions averaged 27 minutes. The enhanced method 
saved an average of 57 minutes per sample when comparing 
the total time to perform both methods. The unenhanced 
method required a total of 54 hours, whereas the modified 
PEG-enhanced method required 17 hours, saving 37 hours 
with enhancement. Enhanced adsorptions with untreated 
adsorbing RBCs alone saved 19.3 hours in addition to the 
time saved by omitting ficin treatment of the adsorbing 
RBCs.
 For all patient samples tested, a 2 × 2 analysis of vari-
ance was calculated. The fixed factors were type of adsorb-
ing RBCs (ficin-treated vs. untreated), and adsorption 
method (modified PEG-enhanced vs. unenhanced). The 
two dependent variables were number of adsorptions and 
time required to remove autoantibodies, and these were 
analyzed separately (Table 3).
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7 E 2 3+ 1 3+




















15 C 1 1+ 2 2+
16 K 2 1+ 2 1+
18 C 2 Not 
detected
1 1+
19 E 3 Not 
detected
1 W+
*Eight samples with no underlying alloantibodies identified.
†Identified with serum adsorbed with ficin-treated adsorbing RBCs.  
For all other antibodies, results were equivalent for ficin-treated and
untreated adsorbing RBCs.
Table 3. Mean number of adsorptions and time to perform adsorp-


















  Ficin-treated (n =19) 1.33 (0.21) 27.27 (4.96)
  Untreated (n = 20) 1.34 (0.22) 26.67 (4.74)
  Average PEG 
  enhanced
1.35 (0.15) 26.97 (3.43) 8.99
Unenhanced method
  Ficin-treated (n =19) 2.12 (0.26) 85.00 (5.81)
  Untreated (n = 20) 2.11 (0.24) 84.44 (5.47)
  Average unenhanced 
  method
2.12 (0.18) 84.72 (3.99) 28.24
*Standard deviation in parentheses.






































18 C Not 
detected
2 1+ 1
19 E Not 
detected
2–4 W+ 1
*Detected with modified PEG-enhanced adsorptions performed 
with ficin-treated adsorbing RBCs only. In all other specimens, 
the unenhanced method required two adsorptions and the PEG-
enhanced method required only one adsorption, and the antibodies 
reacted stronger than those antibodies missed in these specimens.
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Polyethylene glycol adsorptions
 Allogeneic adsorptions with ficin-treated RBCs versus 
untreated RBCs by an unenhanced method resulted in no 
significant differences for number of required adsorptions 
(F [1, 74] = 0.32; p = 0.57) and time required to remove 
autoantibodies (F [1, 73] = 0.20; p = 0.66). In contrast, the 
modified PEG-enhanced adsorption method resulted in sig-
nificantly fewer adsorptions (mean = 1.31, SD = 0.73) than 
the unenhanced method (mean = 2.12, SD = 0.44; F [1, 
74] = 36.22; p = 0.000), and the modified PEG-enhanced 
method required less time in minutes on average (mean = 
26.97, SD = 3.43) than the unenhanced method (mean = 
84.72, SD = 3.99), a significant mean difference (F [1, 73] 
= 324.78; p = 0.000). The interaction between type of ad-
sorbing RBCs and adsorption method was not statistically 
significant, and did not support the hypothesis that com-
bining two enhancements (ficin-treated RBCs and PEG) 
would lead to better results. Ficin treating the adsorbing 
RBCs only made adsorbing cell selection easier.
 The total samples tested included those with underly-
ing alloantibodies identified (n = 12) and those with no al-
loantibodies detected (n = 8). To study those with identified 
alloantibodies separately, similar analyses were performed. 
The same pattern of findings in the subsample was noted. 
The mean number of adsorptions was significantly lower 
for the PEG-enhanced method (mean = 1.35, SD = 0.15) 
compared with the unenhanced method (mean = 2.12, SD = 
0.18; F [1,36] = 5.77; p = 0.002), and the average time was 
less for the PEG-enhanced method (mean = 26.97, SD = 
3.43) than with the unenhanced method (mean = 84.72, SD 
= 3.99; F [1,36] = 120.58; p = 0.000). The comparisons of 
types of adsorbing RBCs (ficin-treated and untreated) were 
not significant.
Discussion   
 For the purpose of this study, all methods used two vol-
umes of RBCs with one volume of serum and one volume 
of PEG (2:1:1) to encourage complete autoantibody adsorp-
tion and to allow subsequent testing of the absorbed serum. 
This ratio provides more available antigen sites to bind with 
the autoantibody. Additionally, the use of untreated versus 
ficin-treated adsorbing RBCs was evaluated with and with-
out PEG-enhanced adsorptions.
 The modified PEG-enhanced procedure improved al-
logeneic adsorption procedures by increasing autoantibody 
adsorption, decreasing the number of adsorptions per-
formed, and subsequently allowing detection of underly-
ing alloantibodies with stronger post enhanced adsorption 
alloantibody reactivity. Using two volumes of adsorbing 
RBCs in combination with the PEG enhancement was com-
parable only to the Liew and Duncan1 method by completely 
removing the autoantibody, allowing antibody detection in 
all cases.
 Previous work regarding enhanced adsorptions is dif-
ficult to compare with this study because of the variability 
of methods and individual technique observed between the 
studies. The range of variables includes incubation time, 
untreated RBCs, chemicals used for treatment of adsorbing 
RBCs (ficin, papain, ZZAP), and the proportions of testing 
materials (1:1:1 as opposed to 2:1:1 in the current study). 
In this study, contrary to that of Barron and Brown,3 weak 
alloantibodies were recovered with PEG adsorptions. The 
results of this study agree with previous works by Leger and 
Garraty4 and Cheng et al.,6 but with even increased effec-
tiveness in antibody removal with the utilization of two vol-
umes of adsorbing RBCs. All PEG-adsorbed samples were 
tested for alloantibodies because the autoantibodies were 
removed. This is an improvement from the Judd and Dake5 
model.
 Antibody detection was possible and the antibody re-
activity was stronger in the modified PEG-enhanced meth-
od. The four antibodies not detected by the unenhanced 
method and the one antibody not detected by the modified 
PEG-enhanced method appear as more weakly reacting 
antibodies among those detected. Perhaps this is explained 
by the difference in the number of adsorptions required be-
tween the two methods for these samples. The variability 
between the modified PEG-enhanced and unenhanced ad-
sorptions in regard to antibody detection may be attribut-
able in part to the fact that PEG is often more sensitive in 
antibody detection than LISS.
 Patients with warm autoantibodies have a mean alloim-
munization rate of 32 percent.9 Maley et al.9 showed an av-
erage underlying alloantibody rate of 30 to 40 percent, and 
their population exhibited 12 percent containing multiple 
alloantibodies. The 20 samples for our study were preferen-
tially selected to include as many alloantibodies as possible 
in the project timeline. Thus, had the samples all been ran-
domly selected, one would have expected fewer samples to 
have had underlying alloantibodies. This was not meant to 
be a true representation of the number of patients exhibit-
ing warm autoantibodies with underlying alloantibodies.
 Neither a moderate enhancement nor a synergistic ef-
fect was observed when using the two enhancement meth-
ods together (ficin-treated RBCs and PEG).
 In conclusion, modified PEG-enhanced adsorptions 
maintained their sensitivity for antibody detection and 
identification while at the same time reducing the number 
of adsorptions and the time required to perform the ad-
sorptions, not to mention the added benefit of reagent and 
labor cost savings. Although the two methods were not sta-
tistically different in regard to antibody detection, the clini-
cal difference is potentially quite large in that the modified 
PEG-enhanced method allowed the detection and identifi-
cation of four additional antibodies known to be clinically 
significant. Using the modified PEG-enhanced method 
to perform allogeneic adsorptions with two volumes of 
RBCs will expedite the availability of appropriate blood for 
patients presenting with warm reactive autoantibodies.
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